ACUTAAS vs MANIPALHOS: Stock Comparison

ACUTAAS CHEMICALS vs MANIPAL HEALTH ENTERPRI LUpdated 17 Sept 26, 11:09 AM ISTNSE & company filings

MANIPAL HEALTH ENTERPRI L is the larger company by market capitalisation. ACUTAAS CHEMICALS shows a higher dividend yield, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ACUTAAS leads 5; MANIPALHOS leads 2 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ACUTAASMANIPALHOS

Valuation lens

What price are you paying?

Market CapContext only
₹26,997 Cr
₹94,970 Cr
P/E RatioSame reading
71.34x
P/B RatioSame reading
16.66x
EPSACUTAAS has the higher reading
₹47.03
₹1.76
Book ValueContext only
₹201.93
Dividend YieldACUTAAS has the higher reading
0.08%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MANIPALHOS is the larger company
₹94,970 Cr vs ₹26,997 Cr
EPS
ACUTAAS has higher earnings per share
₹47.03 vs ₹1.76
Dividend Yield
ACUTAAS has a higher dividend yield
0.08% vs 0%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
MANIPALHOS has stronger quarterly sales growth
194.82% vs -2.2%
Qtr Profit Growth
MANIPALHOS has stronger quarterly profit growth
110.71% vs 1.2%
Net Margin
ACUTAAS has a higher net margin
26.6% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASMANIPALHOS
SectorHealthcare
IndustryPharmaceuticals

Price

MetricACUTAASMANIPALHOS
Live Price₹3,295.7₹721.95
Day Change-1.47%1.03%
Volume93,6533.23 L
52-Week High₹3,740₹815
52-Week Low₹1,302₹625.45
Distance from 52W High-11.88%-11.42%

Valuation

MetricACUTAASMANIPALHOS
Market Cap₹26,997 Cr₹94,970 Cr
P/E Ratio71.34x
P/B Ratio16.66x
EPS₹47.03₹1.76
Book Value₹201.93
Dividend Yield0.08%0%

Growth

MetricACUTAASMANIPALHOS
Revenue Growth (TTM YoY)40.3%0%
EPS Growth (TTM YoY)105.6%0%
Qtr Sales Growth-2.2%194.82%
Qtr Profit Growth1.2%110.71%

Profitability & Leverage

MetricACUTAASMANIPALHOS
ROE20.83%
ROCE23.33%
Net Margin26.6%0%
Operating Margin36.29%
Debt to Equity0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACUTAASMANIPALHOS
Promoter Holding32.66%6.28%
FII Holding21.61% 2.13 pp3.65%
DII Holding19.56% 0.04 pp5.46%
Public Holding26.16% 2.08 pp18.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACUTAAS CHEMICALS and MANIPAL HEALTH ENTERPRI L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.